Kailera Therapeutics, Inc. (KLRA): 10-Q filed Nov 4, 2026

Form type

10-Q

Filing date

Nov 4, 2026

Accession number

0001193125-26-447257

Filer

Kailera Therapeutics, Inc. (CIK 2096997)